Early detection of hearing loss in tuberculosis patient using streptomycin by high frequency distortion product otoacoustic emissions (dpoae) and pure tone audiometry

Combination of Streptomycin, Isoniazid, Rifampicin and Pyrazinamide (SHRZ) are treatment of choice for tuberculosis. Streptomycin is known to cause ototoxicity, nephrotoxicity and neurotoxicity. Distortion product otoacoustic emission (DPOAE) is thought to be more sensitive for early detection of...

Full description

Saved in:
Bibliographic Details
Main Author: Hazama, Mohamad
Format: Monograph
Language:en
Published: Pusat Pengajian Sains Perubatan 2012
Subjects:
Online Access:http://eprints.usm.my/55470/1/DR.%20HAZAMA%20MOHAMAD%20-%20e.pdf
http://eprints.usm.my/55470/
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1834506015202082816
author Hazama, Mohamad
author_facet Hazama, Mohamad
author_sort Hazama, Mohamad
building Hamzah Sendut Library
collection Institutional Repository
content_provider Universiti Sains Malaysia
content_source USM Institutional Repository
continent Asia
country Malaysia
description Combination of Streptomycin, Isoniazid, Rifampicin and Pyrazinamide (SHRZ) are treatment of choice for tuberculosis. Streptomycin is known to cause ototoxicity, nephrotoxicity and neurotoxicity. Distortion product otoacoustic emission (DPOAE) is thought to be more sensitive for early detection of ototoxicity compare to pure tone audiometry (PTA). The aim of this study was to compare these two methods in newly diagnosed tuberculosis patients on streptomycin for early detection of ototoxicity. Ninety six newly diagnosed tuberculosis patients on streptomycin were screened and 50 patients finally included in this study. High frequency DPOAE and PTA were performed at several intervals. The incidence of ototoxicity in this study after completion two months ofiM Streptomycin (15 mglkg daily) is 29.2% (14 patients) using PTA (0.25- 8kHz). While using high frequency DPOAE detected ototoxicity in 77.1 % (37 patients). There was an association between ototoxicity with sex (P =0.011) and age ( P=0.003). There was no association between ototoxicity with other medications taken (P=0.621), pre treatment illness (P=0.140) and urea level (P=l.O). High Frequency (DPOAE) is a good monitoring tool for early detection of ototoxicity in tuberculosis patient on streptomycin compare to PTA.
format Monograph
id my.usm.eprints.55470
institution Universiti Sains Malaysia
language en
publishDate 2012
publisher Pusat Pengajian Sains Perubatan
record_format eprints
spelling my.usm.eprints.55470 http://eprints.usm.my/55470/ Early detection of hearing loss in tuberculosis patient using streptomycin by high frequency distortion product otoacoustic emissions (dpoae) and pure tone audiometry Hazama, Mohamad R5-130.5 General works Combination of Streptomycin, Isoniazid, Rifampicin and Pyrazinamide (SHRZ) are treatment of choice for tuberculosis. Streptomycin is known to cause ototoxicity, nephrotoxicity and neurotoxicity. Distortion product otoacoustic emission (DPOAE) is thought to be more sensitive for early detection of ototoxicity compare to pure tone audiometry (PTA). The aim of this study was to compare these two methods in newly diagnosed tuberculosis patients on streptomycin for early detection of ototoxicity. Ninety six newly diagnosed tuberculosis patients on streptomycin were screened and 50 patients finally included in this study. High frequency DPOAE and PTA were performed at several intervals. The incidence of ototoxicity in this study after completion two months ofiM Streptomycin (15 mglkg daily) is 29.2% (14 patients) using PTA (0.25- 8kHz). While using high frequency DPOAE detected ototoxicity in 77.1 % (37 patients). There was an association between ototoxicity with sex (P =0.011) and age ( P=0.003). There was no association between ototoxicity with other medications taken (P=0.621), pre treatment illness (P=0.140) and urea level (P=l.O). High Frequency (DPOAE) is a good monitoring tool for early detection of ototoxicity in tuberculosis patient on streptomycin compare to PTA. Pusat Pengajian Sains Perubatan 2012 Monograph NonPeerReviewed application/pdf en http://eprints.usm.my/55470/1/DR.%20HAZAMA%20MOHAMAD%20-%20e.pdf Hazama, Mohamad (2012) Early detection of hearing loss in tuberculosis patient using streptomycin by high frequency distortion product otoacoustic emissions (dpoae) and pure tone audiometry. Other. Pusat Pengajian Sains Perubatan. (Submitted)
spellingShingle R5-130.5 General works
Hazama, Mohamad
Early detection of hearing loss in tuberculosis patient using streptomycin by high frequency distortion product otoacoustic emissions (dpoae) and pure tone audiometry
title Early detection of hearing loss in tuberculosis patient using streptomycin by high frequency distortion product otoacoustic emissions (dpoae) and pure tone audiometry
title_full Early detection of hearing loss in tuberculosis patient using streptomycin by high frequency distortion product otoacoustic emissions (dpoae) and pure tone audiometry
title_fullStr Early detection of hearing loss in tuberculosis patient using streptomycin by high frequency distortion product otoacoustic emissions (dpoae) and pure tone audiometry
title_full_unstemmed Early detection of hearing loss in tuberculosis patient using streptomycin by high frequency distortion product otoacoustic emissions (dpoae) and pure tone audiometry
title_short Early detection of hearing loss in tuberculosis patient using streptomycin by high frequency distortion product otoacoustic emissions (dpoae) and pure tone audiometry
title_sort early detection of hearing loss in tuberculosis patient using streptomycin by high frequency distortion product otoacoustic emissions (dpoae) and pure tone audiometry
topic R5-130.5 General works
url http://eprints.usm.my/55470/1/DR.%20HAZAMA%20MOHAMAD%20-%20e.pdf
http://eprints.usm.my/55470/
url_provider http://eprints.usm.my/